70 results
S-3ASR
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
. We have a Fast-Track designation for DCCR in PWS and orphan designation for the drug in the United States (U.S.) and European Union (E.U.).
DCCR
8-K
EX-10.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
function); (iv) federal banking agencies; (v) the U.S. Commodity Futures Trading Commission; or (vi) the U.S. National Credit Union Administration.
Yes … of securities, insurance or banking; or (iii) engaging in savings association or credit union activities?
Yes ☐ No ☐
ii) Was the order (i) entered
8-K
EX-1.1
huuidcagvvvmgprwbe
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
tc5fogw9t
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
kp7t5
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
kw3v2pef3mqt60 vbkqe
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
424B5
zzel39sb3wq ua3uc4e
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
3b50qdep1
28 Mar 22
Prospectus supplement for primary offering
4:53pm